In this Review, we discuss similar preclinical studies that present novel concepts in the neural control of food intake and body weight, with reference to endogenous GLP-1, GLP-1R agonists, and bariatric surgeries like Roux-en-Y gastric bypass (RYGB) and vertical sleeve gastrectomy (VSG), which remain the most effective treatments for severe obesity [9]
At TrimRx, we believe that understanding the clinical landscape is the first step toward a successful and safe health transformation
Another aspect of VC is its ability to modulate anticancer immune responses (39, 95)
Source: Priyanka Sharma, Mint (Livemint) #Pharma #GLP1 #Semaglutide #Pharmacovigilance #IndiaPharma #DrugSafety #Healthcare #Diabetes #Obesity #PharmaStrategy As GLP-1 use expands, diligent monitoring for adverse effects is crucial, particularly in diverse populations
American Diabetes Association (2021) 9